Tag Archives: says

Digital therapeutic approaches seen advancing in 2020, analyst says

The momentum behind digital therapeutics appears to be advancing, despite some chilling of relationships between vendors of the products and pharmaceutical companies. The lack of uniform growth is understandable, contends Richard Close, an analyst with Canaccord Genuity, an investment bank that focuses on growth companies. Close contends that the cooling in activity between digital therapeutic… Read More »